IndiaTickerEP Biocomposites Ltd - 543595 - Press Release On The Financial Results For The Half Year And Year Ended March 31, 2026BSE · financial results · pdf
Source filing Company dossier
EP Biocomposites
BSE:EPBIO · ISIN INE0D2I01014
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
EP Biocomposites
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
EP Biocomposites Ltd - 543595 - Financial Results For The Year Ended March 31, 2026BSE · financial results · pdf
Source filing EP Biocomposites Ltd - 543595 - Board Meeting Outcome for Outcome Of The Board Meeting Along With The Financial Results For The Year Ended March 31, 2026BSE · financial results · pdf
Source filing EP Biocomposites Ltd - 543595 - Board Meeting Intimation for Board Meeting Scheduled To Approve The Financial Results For The Year Ended March 31, 2026BSE · financial results · pdf
Source filing EP Biocomposites Ltd - 543595 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing EP Biocomposites Ltd - 543595 - Intimation Of Press Release - EP Biocomposites Strengthens Technology Capabilities Through Strategic Collaboration With Iisc BengaluruBSE · exchange filing · pdf
Source filing EP Biocomposites Ltd - 543595 - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsBSE · exchange filing · pdf
Source filing EP Biocomposites Ltd - 543595 - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderBSE · exchange filing · pdf
Source filing EP Biocomposites Ltd - 543595 - Financial Results For The Half Year Ended September 30, 2025BSE · financial results · pdf
Source filing EP Biocomposites Ltd - 543595 - Board Meeting Outcome for Outcome Of The Board Meeting- Financial Results For The Half Year Ended September 30, 2025BSE · financial results · pdf
Source filing EP Biocomposites Ltd - 543595 - Board Meeting Intimation for Consideration Of The Financial Results For The Half Year Ended September 30, 2025BSE · financial results · pdf
Source filing EP Biocomposites Ltd - 543595 - Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportBSE · exchange filing · pdf
Source filing EP Biocomposites Ltd - 543595 - Closure of Trading WindowBSE · financial results · pdf
Source filing EP Biocomposites Ltd - 543595 - Shareholder Meeting / Postal Ballot-Outcome of AGMBSE · exchange filing · pdf
Source filing EP Biocomposites Ltd - 543595 - Chairman''s Speech To Be Delivered At The 6Th Annual General MeetingBSE · exchange filing · pdf
Source filing EP Biocomposites Ltd - 543595 - 6Th Annual General Meeting Of The Company And The Annual ReportBSE · annual report · pdf
Source filing EP Biocomposites Ltd - 543595 - Reg. 34 (1) Annual Report.BSE · annual report · pdf
Source filing EP Biocomposites Ltd - 543595 - Announcement Regarding Work Order For Design, Supply, Installation, Testing, Commissioning, And Freight To Site For A Sewage Treatment Plant (Modular STP) With MBBR Technology Having A Capacity Of 225 KLDBSE · exchange filing · pdf
Source filing EP Biocomposites Ltd - 543595 - Voluntary Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Read With SEBI Circular SEBI/HO/CFD/CFD-Pod-1/P/CIR/2023/123 Dated July 13, 2023BSE · exchange filing · pdf
Source filing EP Biocomposites Ltd - 543595 - Integrated Filing (Financial)BSE · financial results · pdf
Source filing EP Biocomposites Ltd - 543595 - Board Meeting Outcome for Half Yearly And Year To Date Results Of The Company For The Half Year Ended March 31, 2025BSE · exchange filing · pdf
Source filing EP Biocomposites Ltd - 543595 - Board Meeting Intimation for Consideration Of The Financial Results For The Year Ended March 31, 2025BSE · financial results · pdf
Source filing EP Biocomposites Ltd - 543595 - Announcement under Regulation 30 (LODR)-Resignation of Chief Executive Officer (CEO)BSE · exchange filing · pdf
Source filing EP Biocomposites Ltd - 543595 - Closure of Trading WindowBSE · financial results · pdf
Source filing EP Biocomposites Ltd - 543595 - Appointment of Company Secretary and Compliance OfficerBSE · exchange filing · pdf
Source filing EP Biocomposites Ltd - 543595 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerBSE · exchange filing · pdf
Source filing EP Biocomposites Ltd - 543595 - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsBSE · exchange filing · pdf
Source filing EP Biocomposites Ltd - 543595 - Board Meeting Outcome for Outcome Of The Board Meeting- Half Yearly Financial ResultsBSE · financial results · pdf
Source filing EP Biocomposites Ltd - 543595 - Announcement under Regulation 30 (LODR)-Resignation of Chief Executive Officer (CEO)BSE · exchange filing · pdf
Source filing EP Biocomposites Ltd - 543595 - Results- Financial Results For The Half-Year Ended September 30, 2024 Along With Limited Review ReportBSE · financial results · pdf
Source filing EP Biocomposites Ltd - 543595 - Board Meeting Intimation for Inter Alia, Consideration Of The Financial Results For The Half-Year Ended September 30, 2024BSE · financial results · pdf
Source filing EP Biocomposites Ltd - 543595 - Shareholder Meeting / Postal Ballot-Outcome of AGMBSE · exchange filing · pdf
Source filing EP Biocomposites Ltd - 543595 - Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportBSE · exchange filing · pdf
Source filing EP Biocomposites Ltd - 543595 - Announcement under Regulation 30 (LODR)-Meeting UpdatesBSE · exchange filing · pdf
Source filing EP Biocomposites Ltd - 543595 - Reg. 34 (1) Annual Report.BSE · annual report · pdf
Source filing EP Biocomposites Ltd - 543595 - Financial Results For The Year Ended 31 March 2024BSE · financial results · pdf
Source filing EP Biocomposites Ltd - 543595 - Board Meeting Outcome for Outcome Of The Board Meeting Dated 25Th May 2024 For Consideration Of Financial ResultsBSE · financial results · pdf
Source filing EP Biocomposites Ltd - 543595 - Board Meeting Intimation for Consideration And Approval Of The Financial Results For The Year Ended 31St March, 2024BSE · financial results · pdf
Source filing EP Biocomposites Ltd - 543595 - Regu. 7 (3) Compliance Certificate For The Financial Year 2023-24BSE · exchange filing · pdf
Source filing EP Biocomposites Ltd - 543595 - Certificate Under Regulation 40 (9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015BSE · exchange filing · pdf
Source filing